ABSTRACT Experimental evidence is presented that supports a cell cycle model showing that there are five distinct biological processes involved in proadipocyte differentiation. These include: (a) growth arrest at a distinct state in the G1 phase of the cell cycle; (b) nonterminal differentiation; (c) terminal differentiation; (d) loss of the differentiated phenotype; and (e) reinitiation of cell proliferation. Each of these events is shown to be regulated by specific human plasma components or other physiological factors. At two states designated GD and GD', coupling of growth arrest and differentiation is shown to occur. We propose that these mechanisms for the coupling of growth arrest and differentiation are physiologically significant and mimic the regulatory processes that control stem cell proliferation in vivo.
Cell proliferation in vivo and in vitro can be regulated by the coupling of growth arrest and cell differentiation (7, 8, l 1, 12, 16) . The mechanisms that control the coupling process have been studied using BALB/c 3T3 T proadipocytes which differentiate into fat ceils in culture (5, 10, 16) . We established that, before expression of the adipocyte phenotype, growth arrest must occur at a state in the G~ phase of the cell cycle, designated GD, and that Go is distinct from other G~ growth arrest states, including those induced by density-dependent growth inhibition, growth factor deprivation, and nutrient deprivation (16) . Only Go-arrested cells: (a) can express the differentiated phenotype in the absence of DNA synthesis (16) ; (b) can be stimulated to proliferate when exposed to methyl isobutyl xanthine (16) ; and (c) are sensitive to a cytotoxic effect of 8-bromo cyclic AMP (6) . The GD arrest state is also distinct from other G1 states on the basis of topographical analysis (19) . In previous studies, however, it has been difficult to distinguish other possible stages in the differentiation process because of technical limitations.
In the preceding paper (10) we described a new culture system that induces proadipocyte GD arrest and differentiation. It was established that culture of low density proadipocytes in heparinized medium containing human plasma induces Go arrest and differentiation in a rapid, highly efficient, and parasynchronous manner. With this method it is now possible to perform more detailed studies on the mechanisms that regulate the coupling process. Data are presented in this paper which provide the basis for a new model that shows that five distinct biological processes are involved in proadipocyte differentiation and that coupling of growth arrest and differentiation occurs at two states, designated GD and Go'.
MATERIALS AND METHODS

General
The BALB/3T3 T proadipocyte cell line was used in this study. To induce Go arrest and differentiation, 3T3 T cells were cultured in heparinized Dulbecco's modified Eagle's medium (DME) containing either 25% human plasma or human plasma fractions as described (10) . The methods used to measure [3H]thymidine incorporation by autoradiography and to perform flow microlluorimetric analysis of the DNA content to characterize cell cycle distribution have been previously described (10, 16) , as have the assays used to determine morphological differentiation (10, 16) . The activity of glycerol-3-phosphate dehydrogenase (9) was also used as an assay for adipocyte differentiation, because it has recently been shown that, under selected culture conditions, cells can undergo enzymatic differentiation in the absence of morphological differentiation (17). The density of undifferentiated and differentiated ceils was quantitated by microscopic analysis using calibrated eyepieces; cell counts assayed between 300 and 500 ceils for each specimen.
previously described in detail (10) . Briefly, citrate anticoagulated plasma was adsorbed repeatedly with barium chloride. This produced barium absorbed plasma (BaP) and plasma components bound to the barium citrate precipitate. Sequential elution of the barium adsorbed plasma components with sodium citrate and ethylenediamine tetraacetic acid produced two fractions designated CEP and EDTAP, respectively.
A second method was developed to produce another fraction with different biological activity. With this method the pH at which the barium adsorption was performed was changed from pH 7.8 to 8.7. More specifically, citrate anticoagulated human plasma was adjusted to pH 8.7 with 1 N NaOH; barium chloride was then added slowly to a final concentration of 0. l M. The pH was readjusted to 8.7 and continuaUy stirred at 4°C for 30 min. The suspension was then centrifuged at 3600 g for 25 min at 4°C. The sediment was finally partially solubilized by addition of 0.9% NaCI4).02 M sodium citrate. This suspension was stirred for 45 rain at 4°C and then sedimented as above. The supernatant, which was extensively dialyzed against 6.5 mM sodium citrate-citric acid buffer (pH 7.4), was designated CEPH. Other methods of procedure are described in detail in the preceding paper (10) .
RESULTS
The culture of rapidly growing low density proadipocytes in heparinized medium containing human plasma induces growth arrest and differentiation. The studies described in this paper were designed to establish: (a) if reversible growth arrest at a distinct state in the G1 phase of the cell cycle precedes differentiation; (b) if the differentiation process involves nonterminal and terminal phases; (c) if nonterminally differentiated cells can be induced to dedifferentiate; and (d) if Go-arrested and dedifferentiated cells can be induced to reinitiate cell proliferation.
Growth Arrest at the G D State
The culture of proadipocytes in heparinized medium containing human plasma induces growth arrest at a distinct state in the GI phase of the cell cycle, Go, and their subsequent differentiation (10, 16). In order to further establish that Go is a specific phase in the coupling process, we attempted to identify experimental conditions that would induce and maintain cells in the Go arrest state in the absence of differentiation and in the absence of DNA synthesis. Three criteria were used to establish that cells were at the GD state. First, cells had to have a 2 N DNA content, which is characteristic of cells growth arrested in the G1 phase of the cell cycle. Second, cells had to show mitogenic responsiveness to methyl isobutyl xanthine (MIX) (16) . Third, the cells had to be capable of expressing the adipocyte phenotype without DNA synthesis (16). The latter two biological characteristics distinguish Go arrested cells from cells arrested at other states in the G1 phase of the cell cycle (16).
Since adsorption of citrated human plasma with barium chloride removes its differentiation-promoting activity, we tested to determine if the culture of proadipocytes in heparinized medium containing barium adsorbed plasma (BaP) induces cells to growth arrest at Go without subsequently expressing a differentiated phenotype. The data presented in Tables I-III support this possibility. Table I shows that culture of proadipocytes in heparinized medium containing BaP induces the growth arrest in >90% of the cells in the G1 phase of the cell cycle. Growth arrest under these culture conditions occurs within 3 d, and the kinetics of growth arrest assayed by decreased incorporation of [3H]thymidine into DNA were comparable to those observed when proadipocytes were cultured in heparmized DME containing complete human plasma. We also observed that cells could be maintained at Go in this medium for intervals as long as 2 wk without loss of viability and without loss of the GD associated characteristics described The distribution of cell populations in various phases of the cell cycle was determined by flow microfluorography using a FACS IV apparatus (see Materials and Methods). BaP designates heparinized DME containing 25% barium adsorbed human plasma. Cells were assayed during exponential growth or after culture in BaP for either 4 or 8 d. Comparable results were obtained for both specimens cultured in heparinized medium containing BaP Cells were growth-arrested by culture in DME-0.5% fetal calf serum (FCS) for 4-6 d or by culture in heparinized DME containing either barium adsorbed human plasma (BaP) or complete human plasma (HP) for 4 to 8 d. To the culture medium was then added methyl isobutyl xanthine, final concentration 5 x 10 -4 M, and [aH]thymidine. Cells were incubated in this medium for 48 h and were then fixed and processed for autoradiographic analysis to determine the extent of DNA synthesis. The data represent the percent labeled nuclei in MiX-treated cells minus the percent labeled nuclei in untreated cells. in the differentiation-competent Go arrest state by culture in heparinized medium containing BaP. The data show that after addition of CEP to cells G1 growth-arrested in beparinized medium containing BaP, differentiation proceeds without DNA synthesis. We interpret these data to support the conclusion that Go arrest and differentiation are separable events.
Nonterminal and Terminal Differentiation
Studies were next performed to determine if the differentiation of proadipocytes is a terminal or a nonterminal process. We first assayed whether adipocyte differentiation in heparinized DME containing human plasma is tightly coupled to the loss of proliferative capacity. The data in Fig. 1 show that there is approximately a 3-d lag between expression of the adipocyte phenotype and loss of proliferative potential, i.e., terminal differentiation. This suggests that a stage of nonterminal differentiation must exist. For example, Fig. 1 shows that on the sixth day, when approximately 50% of the cells are differentiated, 95% can be induced to incorporate [aH]thymidine into DNA. However, after the 12th day, minimal proliferation of differentiated cells can be detected.
To substantiate the possibility that there is a nonterminal phase of adipocyte differentiation, we attempted to identify experimental conditions that would limit the terminal phase of differentiation and thereby enrich cultures in nonterminally differentiated cells. We found that the culture of low density cells in beparinized DME containing a plasma fraction designated CEPH achieved this result. Table IV presents data on the relative ability of human plasma, BaP, and CEPH to induce adipocyte differentiation. It shows that heparinized medium containing only CEPH can induce differentiation comparable to that observed in heparinized medium containing whole plasma. The culture of proadipocytes in medium containing CEPH was also found to induce GL growth arrest. Flow microfluorimetric analysis of such cells showed the following cell cycle distribution: G1, 87%; S, 3%; Gs/M, 10%.
The data in Table V establish that heparinized DME containing CEPH selectively induces nonterminal adipocyte differentiation at a state we have designated GD'. If ceils are cultured in heparinized DME containing CEPH for 8 d or longer, they differentiate but can be induced to lose the differentiated phenotype when exposed to retinoic acid or other Low density proadipocytes were cultured in heparinized DME containing the designated plasma fractions at concentrations calculated to be comparable to 25% whole plasma or in DME containing 10% FC5. Cells were fed these media at 4-d intervals for 12 d and were assayed to the extent of morphological adipocyte differentiation on the 15th day, The results are given as the range in the percent adipocyte differentiation observed in three or more experiments with the indicated plasma fractions. HP designates whole human plasma; the description of the other plasma fractions are detailed in Materials and Methods. Low density cells were cultured in heparinized DMI= containing either 25% human plasma (HP) or CEPH for 12 d with refeeding at 4-d intervals. They showed comparable differentiation kinetics. Retinoic acid (10-20 #g/ml) was then added on the 12th day to one-half of the flasks and the quantity of fat cells present was determined on the 15th day. During this interval a gradual loss of the adipocyte phenotype was morphologically evident in CEPH-treated cells. Since retinoic acid is cytotoxic to some cells, the data have been corrected for maximum potential cytotoxicity. Comparable results were obtained in two separate experiments, FIGURE 1 Nonterminal and terminal phases of adipocyte differentiation. Low density proadipocytes were cultured in heparinized DME containing human plasma. Periodically, the cells were assayed for their extent of differentiation and for their ability to proliferate. For the latter assays, cells were refed DME containing 30% FCS and [3H]thymidine and the percent of the cells that synthesized DNA in the subsequent 48 h was determined autoradiographically. The data show that adipocyte differentiation occurs before the loss of proliferative potential. 1 ).
These observations suggest that nonterminal and terminal adipocyte differentiation are distinct phases in the coupling process and that CEPH lacks the plasma components required for terminal differentiation. The data presented in Table VI support this conclusion. They show that nonterminally differentiated cells cultured in heparinized medium containing CEPH can be converted to a terminally differentiated state by addition of complete human plasma, or the plasma fractions designated BaP or EDTAP, but not by CEP.
Loss of the Differentiated Phenotype
The data reported in Table V and Fig. 2 show that nonterminally differentiated cells can be induced to lose the differentiated phenotype and reinitiate cell proliferation. These two events are separable processes because the data show that, although 67% of nonterminally differentiated cells cultured in heparinized medium containing CEPH can be induced to lose the differentiated phenotype during a 3-d interval in retinoic acid, <1% of the ceils incorporate [3Hlthymidine into DNA during this interval. Reinitiation of proliferation of cells induced to dedifferentiate by retinoic acid requires treatment with serum or other mitogenic agents (Fig. 2) . Loss of the differentiated phenotype and reinitiation of proliferation are, therefore, separate phases in the coupling process. Under selected experimental conditions it is also possible to induce nonterminally differentiated adipocytes to proliferate without loss of the differentiated phenotype (data not shown).
R e i n i t i a t i o n o f C e l l P r o l i f e r a t i o n
Cells which have GD-arrested but which have not expressed the adipocyte phenotype can also be induced to reinitiate DNA synthesis and traverse the cell cycle by addition of a variety of mitogens directly to the differentiation-promoting medium. The data in Table VII list these mitogens. They include epidermal growth factor, phorbol myristate acetate, methyl isobutyl xanthine, 30% fetal calf serum, and a cyst fluid, designated TuGF, which was derived from tumors induced by implantation of BALB/c 3T3 cells on plastic plates into syngeneic mice (4, 15) .
TAatE Vl
Requirements for Specific Plasma Factors to Induce Terminal Adipocyte Differentiation
Loss of the adipocyte phenotype aliquot of complete human plasma (HP), barium adsorbed human plasma (BaP), or the EDTA eluate of barium adsorbed plasma components (EDTAP) was added. The concentration of these additives was equivalent to that calculated to be present in 25% HP. The ability of the adipocytes, cultured under various conditions, to lose the differentiated phenotypes was tested 3-d later by removal of the differentiation-promoting medium and culture of the cells in DME containing 30% fetal calf serum. Loss of the differentiated phenotype is expressed as the percent decrease in the density of fat cells. It was determined by analysis of the number of fat cells/cm 2 present before (control) and 3-d after addition of DME-FCS (treated). Cell density analysis showed that loss of the differentiated phenotypes was not associated with any cytotoxicity. Condition B: Comparable results were obtained when retinoic acid (10-20 p.g/ml) was used to induce loss of the adipocyte phenotype. In these studies low density cells were cultured in heparinized medium containing CEPH for 8 d with feeding at 4-d intervals. On the eighth day the cultures were refed medium containing either HP, BaPor CEP. On the 12th day retinoic acid was added, and loss of the differentiated phenotype was scored 3-d later. Retinoic acid caused some cytotoxicity under these culture conditions. Cytotoxicity was, however, found not to account totally for loss of the adipocyte phenotype. Even if the assumption is made that cytotoxicity affected only differentiated cells, calculations established that retinoic acid induced >20% of adipocytes to lose the differentiated phenotype.
FiGUre 2 Nonterminal adipocyte differentiation: morphological evidence that adipocytes can undergo a proliferative response. Low density cells were cultured for 8 d in heparinized DME containing the plasma fraction designated CEPH to induce nonterminal adipocyte differentiation. They were then maintained in this medium for an additional 3 d with or without (trans) retinoic acid (RA). They were subsequently fed 30% FCS and [aH]thymidine. Cells maintained in medium containing CEPH remained differentiated and did not undergo DNA synthesis (A), whereas many cells treated with RA lost their adipocyte phenotype and incorporated [3H]thymidine into DNA during the subsequent 3-d incubation interval in 30% serum containing medium (B). Some adipocytes, such as those illustrated, became labeled before all of their intracellular triglyceride disappeared. The results of this and related studies established that the minimum quantity of adipocytes that can lose the differentiated phenotype and proliferate in such experiments is 26-37%; the maximum number is ~70%. This range results from the fact that in some cases it is difficult to determine the difference between an undifferentiated cell and a differentiated cell that has been induced to dedifferentiate. Arrows mark nuclei within the cells. In (A) the nuclei are unlabeled, whereas in (B) many [3H]thymidine labeled nuclei are evident.
Correlation Between Morphological and Enzymatic Differentiation
Studies were also performed to establish that the morphological criteria for adipocyte differentiation used in this paper correlate well with enzymatic differentiation assayed by increased activity of glycerol-3-phosphate dehydrogenase. These experiments were performed because of the possibility that under certain culture conditions adipocytes might fail to accumulate intracellular triglyceride and, therefore, appear undifferentiated¢ even though they were differentiated by the criteria of containing high levels of lipogenic enzymes (17). The data in table VIII show that there is an excellent correlation between morpholgoical and enzymatic differentiation of cells at various phases of coupling processes. This further establishes the validity of data reported in this paper which show that the coupling of proadipocyte growth arrest and differentiation is a multistep process that is primarily mediated at two states, designated GD and GD'.
DISCUSSION
These results show that there are at least five biological processes involved in the control of proadipocyte differentiation. Proadipocytes Go-arrested by culture at low density in heparinized DME containing 25% human plasma for 4 d were treated with the listed additives and [3H]thymidine for 48 h. The percentage of cells that synthesize DNA during this interval was determined autoradiographically. The optimum mitogenic concentration for each mitogen is given parenthetically. In all experiments the mitogens were added directly to the heparinized medium containing human plasma. The labeling index for unstimulated cells was typically ~5%. The data are expressed as mean values of experimental specimens (n > 3) minus control specimens. Column one lists the growth or differentiation state of the cells that were assayed. The duration of culture and the various media that were employed to derive these cells are given parenthetically. * ]-he term "dedifferentiated" is used as an abbreviation to designate those nonterminally differentiated cells that have been induced to lose the adipocyte phenotype. Three processes promote differentiation and are regulated by physiological human plasma components. These include: (a) growth arrest at a distinct state in the G E phase of the cell cycle; (b) nonterminal differentiation; and (c) terminal differentiation. Two processes antagonize the differentiation process. These include: (a) the reinitiation of proliferation of arrested cells; and (b) the dedifferentiation and proliferation of nonterminally differentiated cells. A schematic model for the relationship of these stages in the control of proadipocyte proliferation and differentiation is presented in Fig. 3 .
The model illustrates that Go and Go' are states at which coupling of the control of cell proliferation and differentiation can be mediated. Cells growth-arrested at GD, for example, have three potentialities. They can remain GD-arrested; they can be induced to reinitiate proliferation (Fig. 3, arrow 5) ; or they can be induced to nonterminally differentiate (Fig. 3,  arrow 2 ). Nonterminally differentiated cells at the GD' state also have three potentialities. They can remain nonterminally differentiated; they can dedifferentiate and/or reinitiate proliferation (Fig. 3, arrows 4 and 5) ; or they can terminally differentiate (Fig. 3, arrow 3) .
It is our hypothesis that the coupling of proadipocyte growth arrest and differentiation mediated at GD and Go' mimics physiological growth regulation, because in vivo the control of stem cell proliferation is coupled to expression of a differentiated phenotype by apparently similar mechanisms (7, 8, 11 ). For example, in hematopoietic and gastrointestinal stem cells, G1 growth arrest has been shown to occur before differentiation (8, 1 1) . In vivo stages of nonterminal and terminal differentiation have also been identified and it has been shown that the reinitiation of proliferation of such nonterminally differentiated cells can be preceded by a dedifferentiation phase. These latter results were obtained on studies of hepatocytes (1-3).
These observations provide support for the physiological relevance for our model for the coupling of growth arrest and differentiation. Although the coupling process may vary in other cell types, we suggest that our model for the coupling of growth arrest and differentiation will be more useful in explaining the pathogenesis of human disease states than previous models for growth control (13, 18) . For example, our model for growth control can form the basis for the hypothesis that in vivo and in vitro cellular aging results from acceleration in the terminal differentiation process, which is regulated at GD', and that neoplastic transformation results from defective coupling of growth arrest and differentiation mediated at GD or GD' (14, 20) .
